202 related articles for article (PubMed ID: 32416725)
1. Psychopharmacological effects of riparin III from Aniba riparia (Nees) Mez. (Lauraceae) supported by metabolic approach and multivariate data analysis.
Golzio Dos Santos S; Fernandes Gomes I; Fernandes de Oliveira Golzio AM; Lopes Souto A; Scotti MT; Fechine Tavares J; Chavez Gutierrez SJ; Nóbrega de Almeida R; Barbosa-Filho JM; Sobral da Silva M
BMC Complement Med Ther; 2020 May; 20(1):149. PubMed ID: 32416725
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like effects of (O-methyl)-N-2,6-dihydroxybenzoyl-tyramine (riparin III) from Aniba riparia (Nees) Mez (Lauraceae) in mice.
de Melo CT; Monteiro AP; Leite CP; de Araújo FL; Lima VT; Barbosa-Filho JM; de França Fonteles MM; de Vasconcelos SM; de Barros Viana GS; de Sousa FC
Biol Pharm Bull; 2006 Mar; 29(3):451-4. PubMed ID: 16508144
[TBL] [Abstract][Full Text] [Related]
3. Blood matrix effects for male and female Wistar rats, in simultaneous HPLC-UV determination of riparin I and III from Aniba riparia (Nees) Mez. (Lauraceae).
dos Santos SG; Queiroga KF; de Oliveira AM; Tavares JF; Gutierrez SJ; Diniz Mde F; Barbosa-Filho JM; da Silva MS
Talanta; 2011 Oct; 86():233-40. PubMed ID: 22063536
[TBL] [Abstract][Full Text] [Related]
4. Antianxiety and antidepressant effects of riparin III from Aniba riparia (Nees) Mez (Lauraceae) in mice.
Sousa FC; Melo CT; Monteiro AP; Lima VT; Gutierrez SJ; Pereira BA; Barbosa-Filho JM; Vasconcelos SM; Fonteles MF; Viana GS
Pharmacol Biochem Behav; 2004 May; 78(1):27-33. PubMed ID: 15159131
[TBL] [Abstract][Full Text] [Related]
5. Antianxiety effects of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice.
de Sousa FC; Monteiro AP; de Melo CT; de Oliveira GR; Vasconcelos SM; de França Fonteles MM; Gutierrez SJ; Barbosa-Filho JM; Viana GS
Phytother Res; 2005 Dec; 19(12):1005-8. PubMed ID: 16372363
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of effects of N-(2-hydroxybenzoyl) tyramine (riparin II) from Aniba riparia (NEES) MEZ (Lauracea) in anxiety models in mice.
de Sousa FC; Leite CP; de Melo CT; de Araújo FL; Gutierrez SJ; Barbosa-Filho JM; Fonteles MM; de Vasconcelos SM; de Barros Viana GS
Biol Pharm Bull; 2007 Jul; 30(7):1212-6. PubMed ID: 17603155
[TBL] [Abstract][Full Text] [Related]
7. Involvement of monoaminergic system in the antidepressant-like effect of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice.
de Sousa FC; Oliveira IC; Silva MI; de Melo CT; Santiago VR; de Castro Chaves R; Fernandes ML; Gutierrez SJ; Vasconcelos SM; Macêdo DS; Barbosa Filho JM
Fundam Clin Pharmacol; 2014 Feb; 28(1):95-103. PubMed ID: 22913717
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of spasmolytic activity of (O-methyl-)-N-(2,6-dihydroxybenzoyl)tyramine, a constituent of Aniba riparia (Nees) Mez. (Lauraceae), in rat uterus, rabbit aorta and guinea-pig alveolar leucocytes.
Thomas G; Branco UJ; Barbosa Filho JM; Bachelet M; Vargaftig BB
J Pharm Pharmacol; 1994 Feb; 46(2):103-7. PubMed ID: 8021798
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of (O-methyl)-N-benzoyl tyramine (riparin I) from Aniba riparia (Nees) Mez (Lauraceae) in mice.
Araújo FL; Melo CT; Rocha NF; Moura BA; Leite CP; Amaral JF; Barbosa-Filho JM; Gutierrez SJ; Vasconcelos SM; Viana GS; de Sousa FC
Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):337-44. PubMed ID: 19557396
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the antidepressant-like action of riparin III obtained from Aniba riparia (Nees) Mez (Lauraceae) in mice.
Melo CT; de Carvalho AM; Moura BA; Teixeira CP; Vasconcelos LF; Feitosa ML; de Oliveira GV; Barbosa-Filho JM; Chavez Gutierrez SJ; de França Fonteles MM; Vasconcelos SM; de Sousa FC
Fundam Clin Pharmacol; 2013 Feb; 27(1):104-12. PubMed ID: 21793900
[TBL] [Abstract][Full Text] [Related]
11. Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice.
Chaves RC; Mallmann ASV; Oliveira NF; Oliveira ICM; Capibaribe VCC; da Silva DMA; Lopes IS; Valentim JT; de Carvalho AMR; Macêdo DS; Vasconcelos SMM; Gutierrez SJC; Barbosa Filho JM; de Sousa FCF
Pharmacol Biochem Behav; 2019 May; 180():44-51. PubMed ID: 30904544
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effect of riparin II from Aniba riparia in mice: evidence for the involvement of the monoaminergic system.
Teixeira CP; de Melo CT; de Araújo FL; de Carvalho AM; Silva MI; Barbosa-Filho JM; Macêdo DS; de Barros Viana GS; de Sousa FC
Fundam Clin Pharmacol; 2013 Apr; 27(2):129-37. PubMed ID: 21854446
[TBL] [Abstract][Full Text] [Related]
13. Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms.
Lopes IS; Oliveira ICM; Capibaribe VCC; Valentim JT; da Silva DMA; de Souza AG; de Araújo MA; Chaves RC; Gutierrez SJC; Barbosa Filho JM; Macêdo DS; de Sousa FCF
Neurochem Int; 2018 Nov; 120():33-42. PubMed ID: 30041016
[TBL] [Abstract][Full Text] [Related]
14. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
[TBL] [Abstract][Full Text] [Related]
15. Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus.
Vasconcelos AS; Oliveira IC; Vidal LT; Rodrigues GC; Gutierrez SJ; Barbosa-Filho JM; Vasconcelos SM; de França Fonteles MM; Gaspar DM; de Sousa FC
Fundam Clin Pharmacol; 2015 Aug; 29(4):394-403. PubMed ID: 25846646
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant activity of Riparin A in murine model.
Prinholato da Silva C; Oliveira DD; Benincasa BI; Barbar B; Facchin AL; Beleboni RO
Behav Pharmacol; 2021 Oct; 32(7):599-606. PubMed ID: 34483245
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-inflammatory activity of riparin II (O-methil-N-2-hidroxi-benzoyl tyramine) in animal models.
de Carvalho AM; Rocha NF; Vasconcelos LF; Rios ER; Dias ML; Silva MI; de França Fonteles MM; Filho JM; Gutierrez SJ; de Sousa FC
Chem Biol Interact; 2013 Oct; 205(3):165-72. PubMed ID: 23872256
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological investigations, anxiolytic effects and interaction of a semisynthetic riparin with benzodiazepine receptors.
Araújo ÉJF; Rezende-Júnior LM; Lima LKF; Silva-Júnior MPD; Silva OA; Sousa Neto BP; Almeida AAC; Gutierrez SJC; Tomé ADR; Lopes LDS; Ferreira PMP; Lima FDCA
Biomed Pharmacother; 2018 Jul; 103():973-981. PubMed ID: 29710514
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive activity of Riparin II from Aniba riparia: Further elucidation of the possible mechanisms.
Rodrigues de Carvalho AM; Vasconcelos LF; Moura Rocha NF; Vasconcelos Rios ER; Dias ML; Maria de França Fonteles M; Gaspar DM; Barbosa Filho JM; Chavez Gutierrez SJ; Florenço de Sousa FC
Chem Biol Interact; 2018 May; 287():49-56. PubMed ID: 29655911
[TBL] [Abstract][Full Text] [Related]
20. Is Riparin III a promising drug in the treatment for depression?
Mallmann ASV; Chaves RC; de Oliveira NF; Oliveira ICM; Capibaribe VCC; Valentim JT; da Silva DMA; Sartori DP; Rodrigues GC; Filho AJMC; Riello GB; Fonteles MMF; Vasconcelos SMM; Macedo D; Gutierrez SJC; Filho JMB; de Carvalho AMR; de Sousa FCF
Eur J Pharm Sci; 2021 Jul; 162():105824. PubMed ID: 33798709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
